Validation of the new graded prognostic assessment scale for brain metastases: A multicenter prospective study

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Villà, Salvador ^a   Weber, Damien C ^b   Moretones, Cristina ^a   Mañes, Anabel ^a   Combescure, Christophe ^b   Jové, Josep ^a   Puyalto, Paloma ^c   Cuadras, Patricia ^c   Bruna, Jordi ^c   Verger, Eugènia ^d   Balañà, Carme ^a   Graus, Francesc ^d  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c L'Hospitalet ^*  (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BASIC SCORE FOR BRAIN METASTASIS; BRAIN METASTASIS; BREAST CANCER; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GRADED PROGNOSTIC ASSESSMENT SCALE; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MELANOMA; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGNOSIS; PROSPECTIVE STUDY; RATING SCALE; RECURSIVE PARTITIONING ANALYSIS; SCORING SYSTEM; STEREOTACTIC RADIOSURGERY; TREATMENT DURATION; TREATMENT OUTCOME; VALIDATION STUDY; BRAIN TUMOR; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; HEALTH SURVEY; LUNG TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PREDICTIVE VALUE; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HEALTH STATUS INDICATORS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY, CONFORMAL; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 79952077593     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-23     Document Type: Article

References (28)

1. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 1981, 48(2):384-94. 10.1002/1097-0142(19810715)48:2<384::AID-CNCR2820480227>3.0.CO;2-8, 7237407.
2. Sundstrom JT, Minn H, Lertola KK, Nordman E. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Annals of medicine 1998, 30(3):296-9. 10.3109/07853899809005858, 9677016.
3. Sperduto PW. What is your patient's GPA and why does it matter? Managing brain metastases and the cost of hope. International journal of radiation oncology, biology, physics 2010, 77(3):643-4. 10.1016/j.ijrobp.2010.02.038, 20510191.
4. Lutterbach J, Bartelt S, Ostertag C. Long-term survival in patients with brain metastases. Journal of cancer research and clinical oncology 2002, 128(8):417-25. 10.1007/s00432-002-0354-1, 12200598.
5. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. International journal of radiation oncology, biology, physics 1997, 37(4):745-51. 10.1016/S0360-3016(96)00619-0, 9128946.
6. Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. International journal of radiation oncology, biology, physics 2000, 47(4):1001-6. 10.1016/S0360-3016(00)00547-2, 10863071.
7. Nieder C, Nestle U, Motaref B, Walter K, Niewald M, Schnabel K. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?. International journal of radiation oncology, biology, physics 2000, 46(2):297-302. 10.1016/S0360-3016(99)00416-2, 10661335.
8. Tendulkar RD, Liu SW, Barnett GH, Vogelbaum MA, Toms SA, Jin T, et al. RPA classification has prognostic significance for surgically resected single brain metastasis. International journal of radiation oncology, biology, physics 2006, 66(3):810-7. 10.1016/j.ijrobp.2006.06.003, 17011454.
9. Cannady SB, Cavanaugh KA, Lee SY, Bukowski RM, Olencki TE, Stevens GH, et al. Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study. International journal of radiation oncology, biology, physics 2004, 58(1):253-8. 10.1016/S0360-3016(03)00818-6, 14697446.
10. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. International journal of radiation oncology, biology, physics 1999, 43(4):795-803. 10.1016/S0360-3016(98)00442-8, 10098435.
11. Weltman E, Salvajoli JV, Brandt RA, de Morais Hanriot R, Prisco FE, Cruz JC, et al. Radiosurgery for brain metastases: a score index for predicting prognosis. International journal of radiation oncology, biology, physics 2000, 46(5):1155-61. 10.1016/S0360-3016(99)00549-0, 10725626.
12. Lorenzoni J, Devriendt D, Massager N, David P, Ruiz S, Vanderlinden B, et al. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. International journal of radiation oncology, biology, physics 2004, 60(1):218-24. 10.1016/j.ijrobp.2004.02.017, 15337559.
13. Rades D, Dunst J, Schild SE. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 2008, 184(5):251-5. 10.1007/s00066-008-1831-5, 18427755.
14. Rades D, Dziggel L, Haatanen T, Veninga T, Lohynska R, Dunst J, et al. Scoring Systems to Estimate Intracerebral Control and Survival Rates of Patients Irradiated for Brain Metastases. International journal of radiation oncology, biology, physics 2010,
15. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database. International journal of radiation oncology, biology, physics 2008, 70(2):510-4. 10.1016/j.ijrobp.2007.06.074, 17931798.
16. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363(9422):1665-72. 10.1016/S0140-6736(04)16250-8, 15158627.
17. Verger E, Gil M, Yaya R, Vinolas N, Villa S, Pujol T, et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. International journal of radiation oncology, biology, physics 2005, 61(1):185-91. 10.1016/j.ijrobp.2004.04.061, 15629610.
18. Koziol JA, Jia Z. The concordance index C and the Mann-Whitney parameter Pr(X > Y) with randomly censored data. Biom J 2009, 51(3):467-74. 10.1002/bimj.200800228, 19588452.
19. Kaplan E, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958, 53:458-481.
20. Schoenfeld D. Chi-squared goodness-of-fit tests for the proportional hazards regression model. Biometrika 1980, 67:145-153.
21. Quantin C, Abrahamowicz M, Moreau T, Bartlett G, MacKenzie T, Tazi MA, et al. Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. Am J Epidemiol 1999, 150(11):1188-200.
22. Hess KR. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 1995, 14(15):1707-23. 10.1002/sim.4780141510, 7481205.
23. Altman D. Practical Statistics for Medical Research. London 1991, 404-409. Hall C.
24. Nieder C, Geinitz H, Molls M. Validation of the graded prognostic assessment index for surgically treated patients with brain metastases. Anticancer Res 2008, 28(5B):3015-7.
25. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. The New England journal of medicine 2010, 363(8):733-42. 10.1056/NEJMoa1000678, 20818875.
26. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. International journal of radiation oncology, biology, physics 2010, 77(3):655-61. 10.1016/j.ijrobp.2009.08.025, 19942357.
27. Chao ST, Barnett GH, Liu SW, Reuther AM, Toms SA, Vogelbaum MA, et al. Five-year survivors of brain metastases: a single-institution report of 32 patients. International journal of radiation oncology, biology, physics 2006, 66(3):801-9. 10.1016/j.ijrobp.2006.05.015, 16904847.
28. Kaira K, Takahashi T, Murakami H, Tsuya A, Nakamura Y, Naito T, et al. Long-term survivors of more than 5 years in advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2010, 67(1):120-3.